A Positive Psychology Intervention for Patients With Multiple Sclerosis
A Phase I Randomized Controlled Trial of a Positive Psychology Intervention for Patients With Multiple Sclerosis
1 other identifier
interventional
30
1 country
1
Brief Summary
Positive psychology (PP) uses targeted activities to increase the frequency and intensity of positive emotional experiences such as positive affect. Examples of PP activities include recalling positive life events and performing acts of kindness. This pilot study will examine the tolerability and efficacy of a PP training program to increase positive affect in patients with multiple sclerosis (MS). In the intervention phase, subjects randomized to the intervention group will complete five weeks of PP exercises, one exercise per week. Subjects will also have weekly calls with the study trainer. The control group will have no study activities. In the extension phase, subjects in the control group will complete PP training as described above. The investigators will examine the tolerability of the program by calculating the proportion of subjects who complete the program. The investigators will also examine exercise-specific ratings of ease and utility to measure the acceptability of each exercise. Finally, the investigators will evaluate the efficacy of PP training by comparing subjects in the intervention and control groups on measures of positive affect, emotional function, health-related quality of life (HRQOL) and self-reported functional activities such as work. If successful, this study will advance the use of PP as a low cost, innovative and effective tool for increasing positive affect, decreasing depression and anxiety and improving HRQOL in patients with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2018
CompletedFirst Submitted
Initial submission to the registry
August 6, 2018
CompletedFirst Posted
Study publicly available on registry
August 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 9, 2019
CompletedResults Posted
Study results publicly available
August 16, 2021
CompletedAugust 16, 2021
July 1, 2021
1.1 years
August 6, 2018
May 19, 2021
July 22, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of PP Exercises Completed by Subjects
Measured by percentage of PP exercises completed by subjects.
Five weeks
Secondary Outcomes (9)
Subject Ratings of Ease of Completion of PP Exercises
Five weeks
Changes in Affect
Five weeks
Change in Trait Optimism
Five weeks
Change in Depression
Five weeks
Change in Anxiety
Five weeks
- +4 more secondary outcomes
Study Arms (2)
Intervention
OTHERSubjects randomized to the intervention group will be complete five weeks of positive psychology exercises, one exercise per week, during the intervention phase (weeks 1-5) of the study.
Waitlist Control
OTHERSubjects randomized to the waitlist control group will complete five weeks of positive psychology exercises, one exercise per week, during the extension phase (weeks 6-10) of the study.
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of multiple sclerosis according to the McDonald 2010 diagnostic criteria
- Age 18-65
- Ability to speak, read and write in English
- Enrollment in the Comprehensive Longitudinal Investigation of Multiple Sclerosis at the Brigham and Women's Hospital, Partners MS Center: The CLIMB Study.
You may not qualify if:
- Moderate or marked cognitive abnormalities on brief mental status testing identified that would preclude meaningful participation in the PP exercises.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Consortium of Multiple Sclerosis Centerscollaborator
- Massachusetts General Hospitalcollaborator
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
This study had a small sample size and a large number of outcome measures which may limit the ability to see statistically significant changes in health-related quality of life and other psychological outcomes.
Results Point of Contact
- Title
- Bonnie Glanz, PhD
- Organization
- Brigham and Women's Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate
Study Record Dates
First Submitted
August 6, 2018
First Posted
August 20, 2018
Study Start
March 12, 2018
Primary Completion
April 9, 2019
Study Completion
April 9, 2019
Last Updated
August 16, 2021
Results First Posted
August 16, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share